Viewing Study NCT05170659


Ignite Creation Date: 2025-12-24 @ 2:56 PM
Ignite Modification Date: 2025-12-26 @ 12:03 AM
Study NCT ID: NCT05170659
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2022-04-28
First Post: 2021-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access for Relatlimab
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module